Literature DB >> 4713566

Clindamycin in the treatment of serious anaerobic infections.

R J Fass, J F Scholand, G R Hodges, S Saslaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4713566     DOI： 10.7326/0003-4819-78-6-853

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  19 in total

Review 1.  Clindamycin--efficacy and toxicity.

Authors:  R I Frankel
Journal:  West J Med       Date:  1975-06

2.  The effect of cirrhosis on the disposition and elimination of clindamycin.

Authors:  G R Avant; S Schenker; R H Alford
Journal:  Am J Dig Dis       Date:  1975-03

3.  Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.

Authors:  T D Wilkins; L D Smith
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

4.  Treatment of Bacteroides infection with clindamycin-2-phosphate.

Authors:  P C Dickinson; P Saphyakhajon
Journal:  Can Med Assoc J       Date:  1974-11-02       Impact factor: 8.262

5.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

6.  Use of clindamycin in patients with liver disease.

Authors:  D R Hinthorn; L H Baker; D A Romig; K Hassanein; C Liu
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

7.  HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.

Authors:  Y Yang; S Chen; F Yang; L Zhang; G Alterovitz; H Zhu; J Xuan; X Yang; H Luo; J Mu; L He; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2016-08-16       Impact factor: 3.550

8.  Simple assay for clindamycin in the presence of aminoglycosides.

Authors:  F R Ervin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

9.  Effect of clindamycin and lincomycin therapy on faecal flora.

Authors:  D A Leigh; K Simmons
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

10.  In vitro comparison of clindamycin and pirlimycin (U-57930E) activity against Staphylococcus aureus.

Authors:  M E Evans; L S Patterson; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.